1. Focal ¹⁸F-FDG uptake in bone marrow on PET/CT in a patient with JAK2 mutation without overt myeloproliferative neoplasm

   • Akihito Fujimi
   • Yuji Kanisawa
   • Sari Iwasaki

   Images in Hematology 26 November 2013 Pages: 1 - 3

   

2. Expression of different functional isoforms in haematopoiesis

   • Godfrey Grech
   • Joel Pollacco
   • Christian Saliba

   Review Article 01 December 2013 Pages: 4 - 11

   

3. Hepcidin production in response to iron is controlled by monocyte-derived humoral factors

   • Yusuke Sasaki
   • Yasushi Shimonaka
   • Yutaka Kohgo

   Original Article 01 December 2013 Pages: 12 - 20

   

4. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ–TIF2 fusion

   • Haruko Shima
   • Kazutsune Yamagata
   • Issay Kitabayashi

   Original Article 21 November 2013 Pages: 21 - 31

   

5. JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients

   • Margarida Coucelo
   • Gonçalo Caetano
   • M. Letícia Ribeiro

   Original Article 26 November 2013 Pages: 32 - 40

   

6. Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia

   • Takashi Kumagai
   • Eri Matsuki
   • Hisashi Sakamaki

   Original Article 03 December 2013 Pages: 41 - 52

   

7. Distribution of serum erythropoietin levels in lower risk myelodysplastic syndrome cases with anemia

   • Kumi Nakazaki
   • Yasuhito Nannya
   • Mineo Kurokawa

   Original Article 05 December 2013 Pages: 53 - 56

   

8. A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma

   • Shan Shao
   • Xianting Huang
   • Chun Wang

   Original Article 05 December 2013 Pages: 57 - 68

   

9. High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis

   • Lin Gui
   • Yuan-kai Shi
   • Yan Qin

   Original Article 21 November 2013 Pages: 69 - 78

   

10. Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression

    • Yan Li
    • Maimaitili Yimamu
    • Qin Huang

    Original Article 21 November 2013 Pages: 79 - 86

    

11. Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation

    • Weiyi Xu
    • Baode Chen
    • Xiangmin Tong

    Case Report 30 November 2013 Pages: 87 - 90

    

12. Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity

    • Lars Harbaum
    • Andreas Marx
    • Djordje Atanackovic

    Case Report 22 November 2013 Pages: 91 - 94

    

13. Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation

    • Hitoshi Yoshida
    • Kenji Ohshima
    • Jun Ishikawa

    Case Report 22 November 2013 Pages: 95 - 99

    

14. Validation of a new proposed relapse risk score (CBC-score) for acute promyelocytic leukaemia

    • Giuseppina Loglisci
    • Clara Minotti
    • Massimo Breccia

    Letter to the Editor 15 September 2013 Pages: 100 - 101